Trident Texofab EGM on Oct 28 to ratify auditor appointment

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Trident Texofab schedules EGM on October 28, 2026, via VC/OAVM
  • Agenda: Ratify appointment of A Bafna & Associates as statutory auditor
  • Previous auditor Shah Kailash & Associates LLP resigned causing vacancy
  • Remote e-voting window opens October 25, 2026, closes October 27, 2026
powered bylight_fuzz_icon
52568958

*this image is generated using AI for illustrative purposes only.

Trident Texofab Limited has scheduled an Extraordinary General Meeting (EGM) for Wednesday, October 28, 2026, to seek shareholder approval for the appointment of M/s. A Bafna & Associates as its statutory auditor.

The meeting will be held via Video Conferencing or Other Audio Visual Means at 4:00 pm. The agenda focuses on ratifying the appointment made by the Board to fill a casual vacancy caused by the resignation of the previous auditors.

Auditor Appointment Details

The Board of Directors approved the appointment of M/s. A Bafna & Associates, Chartered Accountants (Firm Registration No. 121901W), during a meeting held on October 3, 2026. This appointment fills the casual vacancy resulting from the resignation of M/s. Shah Kailash & Associates LLP, Chartered Accountants (Firm Registration No. 109647W/W100926).

If approved by shareholders, A Bafna & Associates will hold office from the conclusion of this EGM until the next Annual General Meeting. They will conduct the statutory audit for the financial year 2026-27. The remuneration will be fixed by the Chairman in consultation with the Statutory Auditor.

M/s. A Bafna & Associates is a firm registered with the Institute of Chartered Accountants of India (ICAI) with over 20 years of experience in financial consultancy, audit of listed entities, and corporate compliance. The Board reported no relationship between the directors and the newly appointed auditors.

EGM Logistics and Voting Schedule

Shareholders can participate in the EGM through remote e-voting or join the virtual meeting directly. The key dates for the voting process are outlined below:

Event Date Time
Cut-off date for e-voting October 21, 2026 -
Start of remote e-voting October 25, 2026 9:00 am
End of remote e-voting October 27, 2026 5:00 pm
EGM Date October 28, 2026 4:00 pm

The facility for remote e-voting is provided by National Securities Depository Limited (NSDL). Members holding shares in dematerialized form as on the cut-off date are eligible to vote electronically. Institutional investors must send their board resolutions to the scrutinizer, CS Mehul Nanubhai Amareliya, Practicing Company Secretary.

Regulatory Compliance and Notices

The notice for the EGM has been uploaded on the company's website and the BSE website. In line with Ministry of Corporate Affairs circulars, the meeting is being conducted virtually, and physical attendance is not required. Proxy forms are not applicable for this meeting; however, body corporates may appoint authorized representatives.

The explanatory statement confirms that none of the directors, key managerial personnel, or their relatives are financially interested in the resolution. The results of the voting, along with the scrutinizer's report, will be displayed on the company's website immediately after the declaration.

Historical Stock Returns for Trident Texofab

1 Day5 Days1 Month6 Months1 Year5 Years
+1.48%-1.49%-11.82%-56.99%-93.94%-48.92%

What specific reasons led to the resignation of Shah Kailash & Associates LLP, and did it involve any disagreements regarding accounting practices?

How might the change in statutory auditors impact the timeline and reliability of Trident Texofab's upcoming financial disclosures for FY 2026-27?

Will the appointment of A Bafna & Associates lead to any changes in the company's internal control frameworks or compliance strategies given their specific expertise?

Hardik Desai Family Trust acquires 5,412 shares in Trident Texofab

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Hardik Desai Family Trust acquired 5,412 equity shares in the open market
  • Promoter group stake increased from 6.95% to 6.99%
  • Transaction date recorded as September 21, 2026
  • Total equity capital remained unchanged at ₹14,99,57,640
powered bylight_fuzz_icon
51769420

*this image is generated using AI for illustrative purposes only.

Trident Texofab Limited saw a minor increase in promoter group holding following an open market acquisition by the Hardik Desai Family Trust. The trust purchased 5,412 equity shares on September 21, 2026, raising its stake to 6.99% of the company's total voting capital.

The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, by Hardik Jigishkumar Desai, acting as trustee for the family trust. The transaction was executed through the open market route, with no encumbrances or convertible securities involved in the acquisition.

Pre and Post Acquisition Holdings

The acquisition increased the total number of shares held by the promoter group entity from 10,42,334 to 10,47,746. This represents a marginal shift in ownership percentage from 6.95% to 6.99%.

Metric Before Acquisition After Acquisition Change
Shares Held 10,42,334 10,47,746 +5,412
% of Total Voting Capital 6.95% 6.99% +0.04%

Transaction Details

The target company's equity share capital remained unchanged at ₹14,99,57,640, comprising 1,49,95,764 equity shares of ₹10 each. The diluted share capital also remained constant at this level, indicating no outstanding convertible instruments were affected by this trade.

  • Acquirer: Hardik Desai Family Trust (Promoter Group)
  • Mode of Acquisition: Open Market
  • Date of Acquisition: September 21, 2026
  • Number of Shares Acquired: 5,412
  • Listing Exchange: BSE

What the Numbers Show

The acquisition represents a negligible change in the overall shareholding pattern, with a 0.04% increase in the promoter group's stake. The consistency between the pre-acquisition and post-acquisition total diluted capital confirms that the transaction was purely secondary market activity involving existing equity shares, without any dilution from new issuances or conversions.

Historical Stock Returns for Trident Texofab

1 Day5 Days1 Month6 Months1 Year5 Years
+1.48%-1.49%-11.82%-56.99%-93.94%-48.92%

Will the Hardik Desai Family Trust continue to accumulate shares to cross the 7% SEBI disclosure threshold?

How might this incremental promoter buying influence retail investor sentiment and stock liquidity for Trident Texofab?

Are there upcoming regulatory filings or board meetings that could reveal further strategic intentions behind the promoter group's accumulation?

More News on Trident Texofab

1 Year Returns:-93.94%